Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial, Placebo Controlled and Active Comparator, to Evaluate Efficacy and Safety of Neosil in Chronic Effluvium

NCT03659201 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT03659201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03659201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial, Placebo Controlled and Active Comparator, to Evaluate Efficacy and Safety of Neosil in Chronic Effluvium
Lead sponsor
EMS
Phase
Phase 4
Overall status
Completed
Start date
September 3, 2018
Completion date
March 30, 2020
Enrollment
232 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic telogen effluvium